LISTEN LIVE: Loading...

Advertisement

 

Biogen will pay $900 million over kickback allegations

A man walks past the Biogen Inc. headquarters in Cambridge, Mass. (Steven Senne/AP)
A man walks past the Biogen Inc. headquarters in Cambridge, Mass. (Steven Senne/AP)

Cambridge-based Biogen will pay $900 million to settle allegations that it paid doctors to prescribe its drugs.

A federal lawsuit claims the company over-billed Medicare and Medicaid insurance programs when it gave kickbacks to doctors who prescribed its medications.

The allegations came to light when a former Biogen employee reported that between 2009 and 2014, the company paid doctors to prescribe its multiple sclerosis drugs over its competitors, which is a violation of federal law.

While Biogen agreed to pay the settlement, it has not admitted wrongdoing.

Stevee Chapman Associate Producer, Morning Edition
Stevee Chapman is an associate producer for WBUR's Morning Edition.

More…

Advertisement

 
Play
Listen Live
/00:00
Close